Health and Trade Notices




NEW ZEALAND GAZETTE, No. 11 — 2 FEBRUARY 2017

ii. authorise in writing general practitioners receiving clients from Hawke’s Bay District Health Board Opioid Substitution Treatment Service as specified under subsection (2)(d); and

c. authorise in writing general practitioners receiving clients from Hawke’s Bay District Health Board Opioid Substitution Treatment Service as specified under subsection (2)(d).

Conditions

  1. Controlled drugs may only be prescribed, administered or supplied to people who are or have been clients of Hawke’s Bay District Health Board Opioid Substitution Treatment Service.

  2. This approval expires on 31 December 2017.

Dated at Wellington this 7th day of October 2016.

DR JOHN CRAWSHAW, Director of Mental Health.


Notice of Application to Register a Trade Name Product (Notice No. MPI 719)

Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:

Trade Name: Miravis

Reference: P9442

Active Ingredient and Concentration:

Pydiflumetofen 200g/L

Formulation Type: Suspension concentrate

General Use Claim:

For the control of a powdery mildew in grapes and early blight in potato.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

a. must state in full the reasons for making the submission;

b. may state any decision sought on that application; and

c. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

a. where submissions on this application are to be sent;

b. where requests for copies of the public information relating to the application can be sent;

c. where public information relating to the application can be viewed; and

d. the director-general’s address for service:

ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.

The applicant’s address for service is:

Syngenta Crop Protection Limited, Tower 2, Level 7, 110 Symonds Street, Auckland 1010. Postal Address: Private Bag 92618, Symonds Street, Auckland 1010.

Dated at Wellington this 31st day of January 2017.

MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2017, No 11





✨ LLM interpretation of page content

🏥 Approval of Hawke’s Bay District Health Board Opioid Substitution Treatment Service and Clinician (continued from previous page)

🏥 Health & Social Welfare
7 October 2016
Misuse of Drugs Act, Opioid Substitution Treatment, Approval, Hawke’s Bay District Health Board, Clinician
  • DR JOHN CRAWSHAW, Director of Mental Health

🌾 Notice of Application to Register a Trade Name Product

🌾 Primary Industries & Resources
31 January 2017
Trade Name Product, Agricultural Compounds, Veterinary Medicines, Registration, Miravis, Pydiflumetofen
  • Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries